Ratings by Leerink
| Date | Analyst | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|---|
| 10/12/2026 | Will Soghikian | Equillium | EQ | New Coverage | Outperform (N/A) |
6.00 (N/A) |
1.41 (1.19) |
-15.6% | Details |
| 10/12/2026 | Will Soghikian | Connect Biopharma Holdings Ltd | CNTB | New Coverage | Outperform (N/A) |
4.00 (N/A) |
0.87 (0.91) |
4.6% | Details |
![]() |
|||||||||
![]() |
|||||||||
![]() |
|||||||||
![]() |
|||||||||
![]() |
|||||||||
![]() |
|||||||||
![]() |
|||||||||
![]() |
|||||||||
| 4,184 more... | |||||||||



